Drug
Khk4827
Khk4827: highest development phase Phase 3, developed by Kyowa Kirin. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| KHK4827 NCT01782924 | Phase 3 | Psoriasis |
| KHK4827 NCT03957681 | Phase 3 | Moderate to Severe Systemic Sclerosis |
| KHK4827 NCT02982005 | Phase 3 | Moderate to Severe Plaque Psoriasis |
Latest
No recent events.
Follow Khk4827 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.